Advanced or metastatic gastric cancer
Clinical trials for Advanced or metastatic gastric cancer explained in plain language.
Never miss a new study
Get alerted when new Advanced or metastatic gastric cancer trials appear
Sign up with your email to follow new studies for Advanced or metastatic gastric cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer drug trial halted early – what happened?
Disease control Stopped earlyThis phase 2 trial tested the drug futibatinib in 115 people with advanced solid tumors or blood cancers that have specific FGFR gene changes. The goal was to see if the drug could shrink tumors or cause remission. The study was terminated early, so final results are not yet clea…
Matched conditions: ADVANCED OR METASTATIC GASTRIC CANCER
Phase 2 • Sponsor: Taiho Oncology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
A phase II clinical study to evaluate the efficacy and safety of MRG003 in EGFR-Positive, HER2-Negative advanced gastric cancer.
Stopped earlyThe objective of this study is to assess the safety, efficacy, pharmacokinetics, and immunogenicity of MRG003 in patients with EGFR-positive, HER2-negative, inoperable locally advanced or metastatic gastric cancer.
Matched conditions: ADVANCED OR METASTATIC GASTRIC CANCER
Phase 2 • Sponsor: Lepu Biopharma Co., Ltd.
Last updated Sep 09, 2026 17:00 UTC